# Validation of Next Generation Cerebral and Tissue Oximeter

> **NCT03128372** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 32 (actual)

## Conditions studied

- Oxygen Deficiency

## Interventions

- **DEVICE:** Desaturation

## Key facts

- **NCT ID:** NCT03128372
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-22
- **Primary completion:** 2017-07-19
- **Final completion:** 2017-07-19
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03128372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03128372, "Validation of Next Generation Cerebral and Tissue Oximeter". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03128372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*